Vestmark Advisory Solutions’s Pacific Biosciences PACB Stock Holding History

Vestmark Advisory Solutions’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$803K	Sell	478,205 -71,884	-13%	-$105K	0.01%	1024
2026 Q1	$726K	Sell	550,089 -255	-0%	-$456	0.01%	960
2025 Q4	$1.03M	Sell	550,344 -51,179	-9%	-$98.3K	0.01%	788
2025 Q3	$770K	Sell	601,523 -692,663	-54%	-$938K	0.01%	602
2025 Q2	$1.6M	Buy	1,294,186 +612,760	+90%	+$708K	0.02%	411
2025 Q1	$804K	Sell	681,426 -215,632	-24%	-$331K	0.02%	439
2024 Q4	$2M	Buy	897,058 +276,351	+45%	+$539K	0.07%	260
2024 Q3	$1.06M	Sell	620,707 -90,143	-13%	-$148K	0.04%	296
2024 Q2	$974K	Sell	710,850 -224,439	-24%	-$453K	0.04%	316
2024 Q1	$3.51M	Buy	935,289 +440,499	+89%	+$2.58M	0.15%	160
2023 Q4	$4.85M	Buy	+494,790	New	+$4.05M	0.25%	97

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vestmark Advisory Solutions's PACB Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Pacific Biosciences (PACB) stake by 13% in Q2 2026, selling an estimated $105K and leaving 478,205 shares worth $803K. The position accounts for 0.01% of the portfolio, ranked #1024.

Vestmark Advisory Solutions first reported a position in PACB in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.85M in Q4 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Vestmark Advisory Solutions held 478,205 shares of Pacific Biosciences worth $803K as of Q2 2026.
Vestmark Advisory Solutions sold 71,884 Pacific Biosciences shares in Q2 2026, an estimated $105K.
Pacific Biosciences made up 0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #1024 holding.
Vestmark Advisory Solutions first reported a position in Pacific Biosciences in Q4 2023 and has held it in 11 quarters since.
Vestmark Advisory Solutions's Pacific Biosciences position peaked at $4.85M in Q4 2023.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.